Study looks at nicotine gum, smoking cessation
This article was originally published in The Tan Sheet
Executive Summary
Smokers who began nicotine gum treatment four weeks prior to a target date to quit smoking were no less likely to stop smoking or experience withdrawal symptoms than subjects who started using the gum on their quit date, according to a Swiss study. Researchers led by Jean-Francois Etter, of the University of Geneva's Institute of Social and Preventive Medicine, hypothesized that pre-cessation treatment with gum would be more effective than post-cessation treatment because they "thought that obtaining nicotine from gum instead of cigarettes would weaken cigarette reinforcement." The researchers write in a report published June 8 in the Archives of Internal Medicine that the 314 daily smokers studied might have had better success with additional face-to-face counseling or with a nicotine patch, which maintains a steady level of the drug in the bloodstream. Although the study results dispute the status of nicotine gum as a "cut down to quit" product in many countries, the researchers say there remains "a need to explore strategies to increase the reach and efficacy" of nicotine replacement therapies
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.